These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Validity of brief screening questionnaires to detect depression in primary care in Ethiopia. Hanlon C; Medhin G; Selamu M; Breuer E; Worku B; Hailemariam M; Lund C; Prince M; Fekadu A J Affect Disord; 2015 Nov; 186():32-9. PubMed ID: 26226431 [TBL] [Abstract][Full Text] [Related]
43. Sensitivity and specificity of Urdu version of the PHQ-9 to screen depression in patients with coronary artery disease. Gholizadeh L; Ali Khan S; Vahedi F; Davidson PM Contemp Nurse; 2017 Feb; 53(1):75-81. PubMed ID: 28093046 [TBL] [Abstract][Full Text] [Related]
44. Standardization of the korean version of the geriatric depression scale: reliability, validity, and factor structure. Kim JY; Park JH; Lee JJ; Huh Y; Lee SB; Han SK; Choi SW; Lee DY; Kim KW; Woo JI Psychiatry Investig; 2008 Dec; 5(4):232-8. PubMed ID: 20046343 [TBL] [Abstract][Full Text] [Related]
45. [Validation of the Montgomery-Åsberg Depression Rating Scale (MADRS) in Colombia]. Cano JF; Gomez Restrepo C; Rondón M Rev Colomb Psiquiatr; 2016; 45(3):146-55. PubMed ID: 27569008 [TBL] [Abstract][Full Text] [Related]
46. Screening for depression in acute coronary syndrome patients: A comparison of Patient Health Questionnaire-9 versus Hospital Anxiety and Depression Scale-Depression. Yuan J; Ding R; Wang L; Sheng L; Li J; Hu D J Psychosom Res; 2019 Jun; 121():24-28. PubMed ID: 30928210 [TBL] [Abstract][Full Text] [Related]
47. The Patient Health Questionnaire-9 as a Screening Tool for Depression in Individuals with Type 2 Diabetes Mellitus: The Maastricht Study. Janssen EP; Köhler S; Stehouwer CD; Schaper NC; Dagnelie PC; Sep SJ; Henry RM; van der Kallen CJ; Verhey FR; Schram MT J Am Geriatr Soc; 2016 Nov; 64(11):e201-e206. PubMed ID: 27783384 [TBL] [Abstract][Full Text] [Related]
48. The validity and reliability of the Patient Health Questionnaire-9 for screening depression in primary health care patients in Botswana. Molebatsi K; Motlhatlhedi K; Wambua GN BMC Psychiatry; 2020 Jun; 20(1):295. PubMed ID: 32532231 [TBL] [Abstract][Full Text] [Related]
49. Validation and internal consistency of Patient Health Questionnaire-9 for major depression in Parkinson's disease. Chagas MH; Tumas V; Rodrigues GR; Machado-de-Sousa JP; Filho AS; Hallak JE; Crippa JA Age Ageing; 2013 Sep; 42(5):645-9. PubMed ID: 23761457 [TBL] [Abstract][Full Text] [Related]
50. Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia. Sarró S; Dueñas RM; Ramírez N; Arranz B; Martínez R; Sánchez JM; González JM; Saló L; Miralles L; San L Schizophr Res; 2004 Jun; 68(2-3):349-56. PubMed ID: 15099616 [TBL] [Abstract][Full Text] [Related]
51. Summed score of the Patient Health Questionnaire-9 was a reliable and valid method for depression screening in chronically ill elderly patients. Lamers F; Jonkers CC; Bosma H; Penninx BW; Knottnerus JA; van Eijk JT J Clin Epidemiol; 2008 Jul; 61(7):679-87. PubMed ID: 18538262 [TBL] [Abstract][Full Text] [Related]
52. The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer. Hartung TJ; Friedrich M; Johansen C; Wittchen HU; Faller H; Koch U; Brähler E; Härter M; Keller M; Schulz H; Wegscheider K; Weis J; Mehnert A Cancer; 2017 Nov; 123(21):4236-4243. PubMed ID: 28654189 [TBL] [Abstract][Full Text] [Related]
53. Validating screening tools for depression in stroke and transient ischemic attack patients. Prisnie JC; Fiest KM; Coutts SB; Patten SB; Atta CA; Blaikie L; Bulloch AG; Demchuk A; Hill MD; Smith EE; Jetté N Int J Psychiatry Med; 2016 Apr; 51(3):262-77. PubMed ID: 27284119 [TBL] [Abstract][Full Text] [Related]
54. A comparison of psychometric properties between internet and paper versions of two depression instruments (BDI-II and MADRS-S) administered to clinic patients. Holländare F; Andersson G; Engström I J Med Internet Res; 2010 Dec; 12(5):e49. PubMed ID: 21169165 [TBL] [Abstract][Full Text] [Related]
55. A study of the psychometric properties of the Beck Depression Inventory-II, the Montgomery and Åsberg Depression Rating Scale, and the Hospital Anxiety and Depression Scale in a sample from a healthy population. Kjaergaard M; Arfwedson Wang CE; Waterloo K; Jorde R Scand J Psychol; 2014 Feb; 55(1):83-9. PubMed ID: 24256317 [TBL] [Abstract][Full Text] [Related]
56. The Validity of the Montgomery-Asberg Depression Rating Scale in an Inpatient Sample with Alcohol Dependence. Hobden B; Schwandt ML; Carey M; Lee MR; Farokhnia M; Bouhlal S; Oldmeadow C; Leggio L Alcohol Clin Exp Res; 2017 Jun; 41(6):1220-1227. PubMed ID: 28421616 [TBL] [Abstract][Full Text] [Related]
57. Development and preliminary validation of the PC-SAD5, a screener-derived short depression severity measure. Picardi A; Adler DA; Chang H; Lega I; Gigantesco A; Pasquini P; Matteucci G; Zerella MP; Caredda M; Tarsitani L; Biondi M; Rogers WH J Eur Acad Dermatol Venereol; 2012 Feb; 26(2):165-71. PubMed ID: 21395694 [TBL] [Abstract][Full Text] [Related]
58. [Reliability and dimensionality of PHQ-9 in screening depression symptoms among health science students in Cartagena, 2014]. Cassiani-Miranda CA; Vargas-Hernández MC; Pérez-Anibal E; Herazo-Bustos MI; Hernández-Carrillo M Biomedica; 2017 Apr; 37(0):112-120. PubMed ID: 28527273 [TBL] [Abstract][Full Text] [Related]
59. Psychometric properties of the Turkish version of the Patient Health Questionnaire-Somatic, Anxiety, and Depressive Symptoms. Yazici Güleç M; Güleç H; Simşek G; Turhan M; Aydin Sünbül E Compr Psychiatry; 2012 Jul; 53(5):623-9. PubMed ID: 22000476 [TBL] [Abstract][Full Text] [Related]
60. PHQ-9 and PHQ-2 for Screening Depression in Chinese Rural Elderly. Liu ZW; Yu Y; Hu M; Liu HM; Zhou L; Xiao SY PLoS One; 2016; 11(3):e0151042. PubMed ID: 26978264 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]